Boston Trust Walden Corp Sells 4,670 Shares of The Procter & Gamble Company (NYSE:PG)

Posted by Defense World Staff on Jul 3rd, 2023

Boston Trust Walden Corp trimmed its position in shares of The Procter & Gamble Company (NYSE:PG – Free Report) by 1.9% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 238,617 shares of the company’s stock after selling 4,670 shares during the period. Boston Trust Walden Corp’s holdings in Procter & Gamble were worth $35,480,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds have also bought and sold shares of PG. Altus Wealth Management LLC boosted its holdings in shares of Procter & Gamble by 8.5% in the first quarter. Altus Wealth Management LLC now owns 30,345 shares of the company’s stock worth $4,512,000 after acquiring an additional 2,370 shares during the period. Heron Financial Group LLC boosted its holdings in shares of Procter & Gamble by 7.1% in the first quarter. Heron Financial Group LLC now owns 7,691 shares of the company’s stock worth $1,144,000 after acquiring an additional 512 shares during the period. Atwater Malick LLC boosted its holdings in Procter & Gamble by 1.4% during the 1st quarter. Atwater Malick LLC now owns 56,885 shares of the company’s stock valued at $8,458,000 after acquiring an additional 762 shares during the period. TrueWealth Advisors LLC grew its position in Procter & Gamble by 9.1% during the 1st quarter. TrueWealth Advisors LLC now owns 4,069 shares of the company’s stock worth $605,000 after acquiring an additional 340 shares during the last quarter. Finally, Ballast Inc. increased its stake in Procter & Gamble by 6.0% in the 1st quarter. Ballast Inc. now owns 13,757 shares of the company’s stock worth $2,046,000 after purchasing an additional 773 shares during the period. 64.65% of the stock is owned by institutional investors.

Analyst Ratings Changes

PG has been the topic of several analyst reports. UBS Group lifted their target price on shares of Procter & Gamble from $170.00 to $180.00 and gave the stock a “buy” rating in a research note on Monday, April 24th. Morgan Stanley boosted their price objective on shares of Procter & Gamble from $160.00 to $174.00 and gave the company an “overweight” rating in a research report on Monday, April 24th. Raymond James raised their target price on Procter & Gamble from $170.00 to $175.00 and gave the stock an “outperform” rating in a research note on Sunday, April 23rd. StockNews.com initiated coverage on Procter & Gamble in a research note on Thursday, May 18th. They issued a “buy” rating on the stock. Finally, Truist Financial cut Procter & Gamble from a “buy” rating to a “hold” rating and cut their target price for the stock from $165.00 to $155.00 in a research note on Thursday, May 18th. Five research analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $161.50.

Procter & Gamble Price Performance

Shares of PG opened at $151.74 on Monday. The company has a 50 day moving average price of $150.41 and a 200-day moving average price of $147.32. The Procter & Gamble Company has a fifty-two week low of $122.18 and a fifty-two week high of $158.11. The stock has a market capitalization of $357.65 billion, a PE ratio of 26.44, a PEG ratio of 4.22 and a beta of 0.42. The company has a debt-to-equity ratio of 0.51, a quick ratio of 0.39 and a current ratio of 0.59.

Procter & Gamble (NYSE:PG – Free Report) last posted its quarterly earnings results on Friday, April 21st. The company reported $1.37 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.32 by $0.05. The business had revenue of $20.07 billion during the quarter, compared to analysts’ expectations of $19.32 billion. Procter & Gamble had a net margin of 17.69% and a return on equity of 32.18%. The business’s quarterly revenue was up 3.5% on a year-over-year basis. During the same quarter last year, the company posted $1.33 earnings per share. Equities analysts predict that The Procter & Gamble Company will post 5.86 earnings per share for the current fiscal year.

Procter & Gamble Increases Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Monday, May 15th. Stockholders of record on Friday, April 21st were paid a $0.9407 dividend. The ex-dividend date was Thursday, April 20th. This represents a $3.76 dividend on an annualized basis and a dividend yield of 2.48%. This is a positive change from Procter & Gamble’s previous quarterly dividend of $0.91. Procter & Gamble’s dividend payout ratio is presently 65.51%.

Insider Transactions at Procter & Gamble

In other news, COO Shailesh Jejurikar sold 31,000 shares of the stock in a transaction on Monday, May 1st. The shares were sold at an average price of $156.03, for a total value of $4,836,930.00. Following the sale, the chief operating officer now owns 10,014 shares in the company, valued at $1,562,484.42. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. In other news, COO Shailesh Jejurikar sold 31,000 shares of the stock in a transaction on Monday, May 1st. The shares were sold at an average price of $156.03, for a total value of $4,836,930.00. Following the sale, the chief operating officer now owns 10,014 shares in the company, valued at $1,562,484.42. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CFO Andre Schulten sold 25,244 shares of the firm’s stock in a transaction on Monday, April 24th. The shares were sold at an average price of $155.27, for a total transaction of $3,919,635.88. Following the sale, the chief financial officer now owns 27,118 shares in the company, valued at approximately $4,210,611.86. The disclosure for this sale can be found here. Insiders have sold 95,093 shares of company stock worth $14,821,930 over the last 90 days. 0.26% of the stock is currently owned by company insiders.

About Procter & Gamble

(Free Report)

The Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, and SK-II brands.